Evidence map›Paper›PMID 26081601›Full record

ArticleWorld journal of microbiology & biotechnology2015

A central composite rotatable design (CCRD) approach to study the combined effect of antimicrobial agents against bacterial pathogens.

Fernanda Godoy Santos, Layanne Andrade Mendonça, Hilário Cuquetto Mantovani

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Fernanda Godoy SantosDepartamento de Microbiologia, Universidade Federal de Viçosa, Av. PH Rolfs s/n - Campus Universitário, Viçosa, Minas Gerais, CEP 36570-900, Brazil.
Layanne Andrade Mendonça
Hilário Cuquetto Mantovani
Universidade Federal de Viçosa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of antimicrobial agents has been proposed as a therapeutic strategy to control bacterial diseases and to reduce the emergence of antibiotic-resistant strains in clinical environments. In this study, the interaction between the lantibiotic bovicin HC5 with chloramphenicol, gentamicin, nisin, lysostaphin and hydrogen peroxide against Staphylococcus aureus O46 was evaluated by MIC assays. The central composite rotatable design (CCRD), a robust and economic statistical design, was used to combine concentration levels of different antimicrobials agents with distinct mechanisms of action and the presence of significant interactions among the antimicrobials was determined by regression analysis. According to the adjusted model, there were no significant interactions between bovicin HC5 and gentamicin, lysostaphin, nisin or hydrogen peroxide. However, bovicin HC5 showed a significant interaction (P < 0.02) with chloramphenicol. This is the first study applying the CCRD approach to evaluate the combined effect of antimicrobials against S. aureus. Based on our results, this approach is an effective strategy to determine synergistic interactions between antimicrobial agents applied in human and veterinary medicine against bacterial pathogens.

Indexed as

Anti-Bacterial AgentsBacteriocinsChloramphenicolDrug SynergismDrug Therapy, CombinationGentamicinsHumansHydrogen PeroxideLysostaphinMicrobial Sensitivity TestsMicrobial ViabilityNisinRegression AnalysisStaphylococcus aureusAnti-Bacterial AgentsBacteriocinsbovicin HC5, Streptococcus bovis HC5ChloramphenicolGentamicinsHydrogen PeroxideLysostaphinNisin

Identifiers

PMID26081601
OpenAlexW2111698612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.